文献速递乳腺US乳腺X线

乳腺超声非肿块病变:阅片者间一致性及其与恶性的关联

Nonmass Lesions on Breast Ultrasound: Interreader Agreement and Associations With Malignancy.
PubMed 文献 · AJR Am J Roentgenol · 2024-12-18

本回顾性研究纳入2007例患者2381个乳腺病灶,评估超声非肿块病变(NML)分类的阅片者间一致性及恶性相关影像特征。两位放射科医师独立分类的一致性为κ=0.73,317个(13.3%)病灶被分类为NML,其中42.0%为恶性,30.8%的恶性NML无相应钼靶异常。超声上钙化、后方声影和不平行方位对恶性识别准确率最高。

要点

  • 超声NML分类的阅片者间一致性为κ=0.73,初始不一致的101个病灶经共识复核后归为NML。
  • 超声上钙化(准确率65.6%)、后方声影(62.8%)和不平行方位(59.3%)对NML恶性识别准确率最高。
  • 多变量分析中,超声不平行方位(OR=8.8)、后方声影(OR=6.3)和钙化(OR=8.9)与恶性独立相关。

核心结论

  • 基于现有定义,超声NML分类存在阅片者间差异,影像特征对判断NML恶性有潜在价值;需进一步精确和澄清NML定义,并进一步研究确定哪些NML恶性风险最高。

研究设计与样本

  • 回顾性研究,纳入2007例患者(2005例女性、2例男性,平均年龄54.0±9.6岁)的2381个乳腺病灶,2020年1月至2020年12月行超声引导下活检;两位放射科医师独立将病灶分类为肿块或NML(采用北美放射学会2023年年会报告中的NML定义),对不一致病例尝试达成共识;另由一位放射科医师记录NML的钼靶和超声特征;病理结果取自电子健康档案。

关键影像表现/征象

  • 超声上钙化、后方声影和不平行方位是识别NML恶性准确率最高的征象,准确率分别为65.6%、62.8%和59.3%。
  • 30.8%的恶性NML无相应钼靶异常。

诊断标准与关键数值

  • 病灶分类(肿块 vs NML)的阅片者间一致性为κ=0.73。
  • 2381个病灶中317个(13.3%)被分类为NML;317个中101个(31.9%)初始阅片者不一致。
  • 317个NML中133个(42.0%)为恶性,包括浸润性导管癌48/133、导管原位癌43/133、微浸润性导管癌34/133。
  • 多变量分析中与恶性独立相关的变量:钼靶钙化(OR=8.9)、钼靶不对称(OR=4.7)、钼靶肿块(OR=6.4);超声较大尺寸(OR=1.03)、超声不平行方位(OR=8.8)、超声后方声影(OR=6.3)。

临床应用与阅片要点

  • 阅片时可参照本研究所用NML定义对病灶进行分类,注意初始阅片者间不一致率达31.9%。
  • 对超声NML应关注钙化、后方声影和不平行方位等与恶性相关的征象。
  • 恶性NML中30.8%无相应钼靶异常,钼靶阴性不能除外NML恶性。
  • 作者指出需进一步精确和澄清NML定义,并进一步研究确定哪些NML恶性风险最高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Nonmass lesions (NMLs) on breast ultrasound lack clear definition and encompass a broad range of benign and malignant entities. Given the anticipated inclusion of NMLs in the BI-RADS 6th edition, a thorough understanding of these lesions will be critical for their optimal management. OBJECTIVE. The purpose of the present study was to evaluate interreader agreement for classification of lesions observed on breast ultrasound as NMLs and to identify the imaging features associated with malignancy in these lesions. METHODS. This retrospective study included 2007 patients (2005 women and two men; mean age, 54.0 ± 9.6 [SD] years) who underwent ultrasound-guided biopsy of 2381 breast lesions between January 2020 and December 2020. Two radiologists independently classified the lesions as masses or NMLs, using a definition of NMLs from a presentation at the Radiological Society of North America 2023 annual meeting. The radiologists attempted to reach consensus for discordant cases. Another radiologist recorded the mammographic and ultrasound characteristics of the NMLs. Pathologic outcomes for NMLs were extracted from the EHR. RESULTS. Interreader agreement for lesion classification (mass vs NML) was substantial (κ = 0.73) A total of 216 lesions were classified as NMLs by both readers independently; an additional 101 lesions were classified as NMLs by consensus review after initial discordance. Thus, 317 of 2381 lesions (13.3%) were classified as NMLs; initial reader discordance occurred for 101 of these 317 lesions (31.9%). A total of 133 of 317 NMLs (42.0%) were malignant, including invasive ductal carcinoma (48/133), ductal carcinoma in situ (43/133), and microinvasive ductal carcinoma (micro-IDC) (34/133). A total of 30.8% of malignant NMLs lacked correlative mammographic abnormalities. Ultrasound findings with the highest accuracy for identifying malignancy of NMLs were calcifications (65.6%), posterior shadowing (62.8%), and nonparallel orientation (59.3%). In multivariable analysis, variables showing significant independent associations with malignancy included calcifications (OR = 8.9), asymmetry (OR = 4.7), and mass (OR = 6.4) on mammography and greater size (OR = 1.03), nonparallel orientation (OR = 8.8), and posterior shadowing (OR = 6.3) on ultrasound. CONCLUSION. The analysis provides insights regarding reader variability for classifying ultrasound lesions as NMLs on the basis of an existing definition as well as regarding the potential utility of imaging findings for characterizing such lesions as malignant. CLINICAL IMPACT. These findings indicate the need for further precision and clarification regarding the definition of NMLs and for further investigation to determine which NMLs have the greatest malignancy risk.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Cho SM, Cha JH, Kim HH, et al. Nonmass Lesions on Breast Ultrasound: Interreader Agreement and Associations With Malignancy. AJR Am J Roentgenol. 2024. PMID: 39692305. doi:10.2214/AJR.24.32278

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。